medsovetМедицинский СоветMeditsinskiy sovet = Medical Council2079-701X2658-5790REMEDIUM GROUP Ltd.10.21518/2079-701X-2015-11-36-41medsovet-286Research ArticleБРОНХОПУЛЬМОНОЛОГИЯ, ЛОРBRONCHOPULMONOLOGY, ENTВозможности контроля пыльцевой бронхиальной астмы с помощью режима единого ингалятора: случай из практикиManaging pollen asthma with a single inhaler: a case studyНенашеваН. М.NenashevaN. M.noemail@neicon.ruРоссийская медицинская академия последипломного образования, МоскваРоссияRussian Medical Academy of Postgraduate Education, MoscowRussian Federation2015301220150113641Copyright © Ненашева Н.М., 20152015Ненашева Н.М.Nenasheva N.M.Данная работа распространяется под лицензией Creative Commons Attribution 4.0.This work is licensed under a Creative Commons Attribution 4.0 License.https://www.med-sovet.pro/jour/article/view/286

Согласно определению, предложенному международным руководством GINA («Глобальная инициатива по бронхиальной астме» (Global Initiative for Asthma)) в 2014 г., бронхиальная астма (БА) является гетерогенным заболеванием, обычно характеризующимся хроническим воспалением дыхательных путей, и определяется историей респираторных симптомов, таких как свистящие хрипы, одышка, заложенность в груди и кашель, которые варьируют по времени и интенсивности и проявляются вместе с вариабельной обструкцией дыхательных путей [1].

According to the definition proposed by the global leadership of GINA (Global Initiative for Asthma) in 2014, asthma is a heterogeneous disease, usually characterized by chronic airway inflammation. It is defined by the history of respiratory symptoms such as wheeze, shortness of breath, chest tightness and cough that vary over time and in intensity, together with variable expiratory airflow limitation. [1]

пыльцевая бронхиальная астмабудесонид/формотеролСимбикортpollen asthmabudesonide/formoterolSymbicortReferenceswww.ginasthma. Com.www.ginasthma. Com.Akdis C, Agache I. Global Atlas of Asthma. Published by the EAACI, 2013, 180 p.Akdis C, Agache I. Global Atlas of Asthma. Published by the EAACI, 2013, 180 p.Calderon M, Linneberg A, Kleine-Tebbe J, et al. Respiratory allergy caused by house dust mites: What do we really know? J Allergy Clin Immunol, 2015. 136: 38-48Calderon M, Linneberg A, Kleine-Tebbe J, et al. Respiratory allergy caused by house dust mites: What do we really know? J Allergy Clin Immunol, 2015. 136: 38-48Ненашева Н.М. Клинические фенотипы атопической бронхиальной астмы. Диагностика и лечение. Saarbrucken, Germany Palmarium Academic Publishing, 2012, 319 с.Ненашева Н.М. Клинические фенотипы атопической бронхиальной астмы. Диагностика и лечение. Saarbrucken, Germany Palmarium Academic Publishing, 2012, 319 с.Schappi GF, Taylor PE, Staff IA, Rolland JM, Suphioglu C. Immunologic significance of res-pirable atmospheric starch granules containing major birch allergen Bet v 1. Allergy, 1999. 54: 478-83.Schappi GF, Taylor PE, Staff IA, Rolland JM, Suphioglu C. Immunologic significance of res-pirable atmospheric starch granules containing major birch allergen Bet v 1. Allergy, 1999. 54: 478-83.Grote M, Vrtala S, Niederberger V, Valenta R, Reichelt R. Expulsion of allergen-containing materials from hydrated rye grass (Lolium per-enne) pollen revealed by using immunogold field emission scanning and transmission electron microscopy. J Allergy Clin Immunol., 2000. 105: 1140-5.Grote M, Vrtala S, Niederberger V, Valenta R, Reichelt R. Expulsion of allergen-containing materials from hydrated rye grass (Lolium per-enne) pollen revealed by using immunogold field emission scanning and transmission electron microscopy. J Allergy Clin Immunol., 2000. 105: 1140-5.Taylor PE, Flagan RC, Miguel AG, Valenta R, Glovsky MM. Birch pollen rupture and the release of aerosols of respirable allergens. Clin Exp Allergy, 2004. 34: 1591-6.Taylor PE, Flagan RC, Miguel AG, Valenta R, Glovsky MM. Birch pollen rupture and the release of aerosols of respirable allergens. Clin Exp Allergy, 2004. 34: 1591-6.Wark PA, Simpson J, Hensley MJ, Gibson PG. Airway inflammation in thunderstorm asthma. Clin Exp Allergy, 2002. 32: 1750-6.Wark PA, Simpson J, Hensley MJ, Gibson PG. Airway inflammation in thunderstorm asthma. Clin Exp Allergy, 2002. 32: 1750-6.Bacsi A, Choudhury BK, Dharajiya N, Sur S, Boldogh I. Subpollen particles: Carriers of allergenic proteins and oxidases. The Journal of allergy and clinical immunology, 2006.118(4): 844-850.Bacsi A, Choudhury BK, Dharajiya N, Sur S, Boldogh I. Subpollen particles: Carriers of allergenic proteins and oxidases. The Journal of allergy and clinical immunology, 2006.118(4): 844-850.Gibson PG, Saltos N, Fakes K. Acute anti-inflammatory effects of inhaled budesonide in asthma: a randomized controlled trial. Am J Respir Crit Care Med, 2001. 163: 32-36.Gibson PG, Saltos N, Fakes K. Acute anti-inflammatory effects of inhaled budesonide in asthma: a randomized controlled trial. Am J Respir Crit Care Med, 2001. 163: 32-36.Toogood JH, Baskerville JC, Jennings B, Lefcoe NM, Johansson SA. Influence of dosing frequency and schedule on the response of chronic asthmatics to the aerosol steroid, budesonide. J Allergy Clin Immunol. 1982. 70(4): 288-98.Toogood JH, Baskerville JC, Jennings B, Lefcoe NM, Johansson SA. Influence of dosing frequency and schedule on the response of chronic asthmatics to the aerosol steroid, budesonide. J Allergy Clin Immunol. 1982. 70(4): 288-98.Kelly M, O'Connor T, Leigh R, et al. Effects of budesonide and formoterol on allergen-induced airway responses, inflammation, and airway remodeling in asthma. J Allergy Clin Immunol, 2010. 125: 349-56.Kelly M, O'Connor T, Leigh R, et al. Effects of budesonide and formoterol on allergen-induced airway responses, inflammation, and airway remodeling in asthma. J Allergy Clin Immunol, 2010. 125: 349-56.Bateman ED, Harrison TW, Ouirce S, et al. Overall asthma control achieved with budeso-nide/formoterol maintenance and reliever therapy for patients on different treatment steps. Respir Res, 2011. 12: 38.Bateman ED, Harrison TW, Ouirce S, et al. Overall asthma control achieved with budeso-nide/formoterol maintenance and reliever therapy for patients on different treatment steps. Respir Res, 2011. 12: 38.Архипов В.В., Григорьева Е.В., Гавришина Е.В. Контроль над бронхиальной астмой в России: результаты многоцентрового наблюдательного исследования НИКА. Пульмонология, 2011. 6: 87-93.Архипов В.В., Григорьева Е.В., Гавришина Е.В. Контроль над бронхиальной астмой в России: результаты многоцентрового наблюдательного исследования НИКА. Пульмонология, 2011. 6: 87-93.Nanshan Zhong, Jiangtao Lin, Parthiv Mehta, et al. Real-life Effectiveness of Budesonide/ Formoterol Maintenance and Reliever Therapy in Asthma Patients Across Asia. BMC Pulm Med., 2013. 13(22).Nanshan Zhong, Jiangtao Lin, Parthiv Mehta, et al. Real-life Effectiveness of Budesonide/ Formoterol Maintenance and Reliever Therapy in Asthma Patients Across Asia. BMC Pulm Med., 2013. 13(22).

The authors declare that there are no conflicts of interest present.